Latham & Watkins Advises on Medline’s US$2 Billion Senior Notes Offering and US$2.7 Billion Secondary Offering of Common Stock

Medline Borrower, LP and Medline Co-Issuer, Inc., indirect subsidiaries of Medline Inc. (Nasdaq: MDLN) (Medline), closed on May 28, 2026 an offering of senior secured notes in an aggregate principal amount of US$2 billion, consisting of US$1.25 billion of 5.000% senior secured notes due 2031 and US$750 million of 5.250% senior secured notes due 2033. Medline also announced the closing of its upsized secondary offering of 72,554,594 shares of Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC, and a wholly owned subsidiary of the Abu Dhabi Investment Authority at a price to the public of US$37.00 per share. The selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Class A common stock. 

Latham & Watkins LLP represented the banks in both offerings with a Capital Markets team led by partners Jason Licht and Cathy Birkeland and counsel Christopher Cronin, with associates Ben Winnett, Gabrielle Blum, Chelsea Carlson, Caroline Hughes, and Andrew Johnson. Advice was also provided on tax matters by partner Christine Mainguy, with associate Nolon Blaylock; and on banking matters by partner Zulf Bokhari and counsel Andrea Keller, with associates Rob Rogowski and Samantha Rudd.